Vaccine Packaging at the Clinical Interface of Vaccine, Healthcare Worker, and Patient - Packaging vaccines using prefilled syringes can increase dosing efficiency, reduce costs, and improve patient s

ADVERTISEMENT

Vaccine Packaging at the Clinical Interface of Vaccine, Healthcare Worker, and Patient
Packaging vaccines using prefilled syringes can increase dosing efficiency, reduce costs, and improve patient safety. This article is part of a special section on vaccines.


BioPharm International
Volume 25, Issue 10, pp. 34-36

REFERENCES

1. F. Zhou, presention at the 45th National Immunization Conference (Washington, DC, March 2011).

2. US Dept. of Health and Human Services, 2010 National Vaccine Plan, http://www.hhs.gov/nvpo/vacc_plan/2010%20Plan/nationalvaccineplan.pdf, accessed Sept. 10, 2012.

3. Health Industry Distributors Association, 2010–2011 Influenza Vaccine Production and Distribution Market Brief (Sept. 2011).

4. C.C. Pereira and D. Bishai, Expert Reviews 9 (11), 1343–1349 (2010).

5. CDC, The Pink Book—Epidemiology and Prevention of Vaccine-Preventable Diseases, W. Atkinson, S. Wolfe, and J. Hamborsky, eds, (Public Health Foundation, 12th ed., Washington DC, 2011).

6. D. Bishai, presentation at the World Vaccine Congress, (Washington DC, Apr. 2010).

7. Advisory Committee on Immunization Practices, MMWR 55 (RR15), 1–48 (2006).

8. G. Pugliese et al., Am J Infect Control 38 (10), 789–98 (2010).

9. New York State Department of Health, "Nassau County and State Health Departments Alert 36 Patients to Infection Control Error by Long Island Doctor," Press Release, Albany, NY, Jan. 15, 2008.

10. Experts123, "Why is Human Factors Engineering Important for Medical Devices?" http://www.experts123.com/q/why-is-human-factors-engineering-important-for-medical-devices.html, accessed Sept. 24, 2012.

11. Interface Analysis Associates, Vaccine Primary Drug Container: Single-Dose, Multi-Dose, Pre-Filled Syringe Risks Analysis Report. On file at BD (2011).

12. Company Reports, IMS Data, National Influenza Vaccine Summits, BD Market Intelligence (2006–2012).

13. BD Market Intelligence (2009).


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here